Advances in treatment of axial spondyloarthritis are associated with improved patient outcomes: data from the Ankylosing Spondylitis Registry of Ireland (ASRI) (2022)
https://pubmed.ncbi.nlm.nih.gov/35088133/

COVID-19: What Do Rheumatologists Need to Know? (2021)
https://pubmed.ncbi.nlm.nih.gov/33403528/

Employment and Functional Ability in Men and Women With Axial Spondyloarthritis as Described in the US-based Corrona Psoriatic Arthritis/Spondyloarthritis Registry (2021)
https://pubmed.ncbi.nlm.nih.gov/34470800/

Pharmacological treatment for managing bone health in axial spondyloarthropathy: systematic review and meta-analysis (2020)
https://pubmed.ncbi.nlm.nih.gov/32556472/

Measuring bone density in axial spondyloarthropathy: Time to turn things on their side? (2020)
https://pubmed.ncbi.nlm.nih.gov/31909570/

Calcaneal quantitative ultrasound has a role in out ruling low bone mineral density in axial spondyloarthropathy (2020)
https://pubmed.ncbi.nlm.nih.gov/31953568/

Multimorbidity in Axial Spondyloarthropathy and Its Association with Disease Outcomes: Results from the Ankylosing Spondylitis Registry of Ireland Cohort (2020)
https://pubmed.ncbi.nlm.nih.gov/31092715/

The Fascinating Paradox of Osteoporosis in Axial Spondyloarthropathy (2017)
https://pubmed.ncbi.nlm.nih.gov/28966207/